MOSYAK; Lidia
Patent Applications and Registrations
Patent applications and USPTO patent grants for MOSYAK; Lidia.The latest application filed is for "cdcp1-targeted therapies".
- MOSYAK; Lidia - Newton MA
- Mosyak; Lidia - Newton Center MA
| Patent | Date |
|---|---|
| Cdcp1-targeted Therapies App 20220119545 - CANTLEY; Lewis C. ; et al. | 2022-04-21 |
| Dual PDGF/VEGF antagonists Grant 11,155,610 - Perlroth , et al. October 26, 2 | 2021-10-26 |
| IL-15 Variants and Uses Thereof App 20210324028 - Yeung; Yik Andy ; et al. | 2021-10-21 |
| IL-15 variants and uses thereof Grant 11,059,876 - Yeung , et al. July 13, 2 | 2021-07-13 |
| Interferon Beta Antibodies And Uses Thereof App 20210163588 - Gulla; Stefano V. ; et al. | 2021-06-03 |
| Interferon beta antibodies and uses thereof Grant 10,829,553 - Gulla , et al. November 10, 2 | 2020-11-10 |
| Dual Pdgf/vegf Antagonists App 20200262905 - Perlroth; D. Victor ; et al. | 2020-08-20 |
| Antibodies Specific For Gucy2c And Uses Thereof App 20200010566 - Chang; Chew Shun ; et al. | 2020-01-09 |
| IL-15 Variants and Uses Thereof App 20190263877 - Yeung; Yik Andy ; et al. | 2019-08-29 |
| Dual Pdgf/vegf Antagonists App 20180244762 - Perlroth; D. Victor ; et al. | 2018-08-30 |
| Bispecific Heterodimeric Diabodies And Uses Thereof App 20180155452 - May; Chad Michael ; et al. | 2018-06-07 |
| Bispecific heterodimeric diabodies and uses thereof Grant 9,884,921 - May , et al. February 6, 2 | 2018-02-06 |
| Dual PDGF/VEGF antagonists Grant 9,840,553 - Perlroth , et al. December 12, 2 | 2017-12-12 |
| Interferon Beta Antibodies And Uses Thereof App 20170313769 - Gulla; Stefano V. ; et al. | 2017-11-02 |
| Anti-glucagon Receptor Antibodies And Methods Of Use Thereof App 20160311912 - Forgie; Alison Jane ; et al. | 2016-10-27 |
| Anti-glucagon receptor antibodies and pharmaceutical compositions thereof Grant 9,248,189 - Forgie , et al. February 2, 2 | 2016-02-02 |
| Bispecific Heterodimeric Diabodies And Uses Thereof App 20160002357 - MAY; Chad Michael ; et al. | 2016-01-07 |
| Dual Pdgf/vegf Antagonists App 20150376271 - Perlroth; D. Victor ; et al. | 2015-12-31 |
| Anti-glucagon Receptor Antibodies And Methods Of Use Thereof App 20140335091 - FORGIE; Alison Jane ; et al. | 2014-11-13 |
| Method for identifying or designing a candidate agent that interacts with LINGO-1 polypeptide using a LINGO-1 three-dimensional structure Grant 7,693,698 - Mosyak , et al. April 6, 2 | 2010-04-06 |
| Aggrecanase structure Grant 7,615,363 - Mosyak , et al. November 10, 2 | 2009-11-10 |
| Structure of protein kinase C theta Grant 7,584,087 - Xu , et al. September 1, 2 | 2009-09-01 |
| Methods for the design of estrogen receptor ligands Grant 7,555,415 - Mosyak , et al. June 30, 2 | 2009-06-30 |
| LINGO-1 structure App 20070274918 - Mosyak; Lidia ; et al. | 2007-11-29 |
| Crystal structures of MK2 and uses thereof App 20070100560 - Parris; Kevin D. ; et al. | 2007-05-03 |
| Anti-IL-13 antibodies and complexes App 20070048785 - Lin; Laura Long ; et al. | 2007-03-01 |
| Methods for identifying agents that interact with MAP kinase activated protein kinase 2 Grant 7,167,802 - Parris , et al. January 23, 2 | 2007-01-23 |
| Estrogen receptor structure App 20060160836 - Mosyak; Lidia ; et al. | 2006-07-20 |
| Structure of protein kinase C theta App 20060003431 - Xu; Zhang Bao ; et al. | 2006-01-05 |
| Crystal structures of MK2 and uses thereof App 20040091872 - Parris, Kevin D. ; et al. | 2004-05-13 |
| Crystal structures of Kv channel proteins and uses thereof App 20040091908 - Xu, Weixin ; et al. | 2004-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 